Inventor · disambiguated record
Hampar L. Karageozian
Also filed as: KARAGEOZIAN HAMPAR · KARAGEOZIAN HAMPAR L
31 granted patents·17 pending applications·928 citations·filing 1972–2025
98Inventor score
Files withALLEGRO PHARMACEUTICALS LLC9S K PHARMACEUTICALS INC6ISTA PHARMACEUTICALS INC5ALLERGAN INC4KARAGEOZIAN HAMPAR L3
Top patents by PatentIndex Score
48 records- 0198US8012115B2Optic nerve implantsS K PHARMACEUTICALS INC·Filed 2008·Granted Sep 6, 2011·62 cites·12 claims
- 0295US6488965B1Synergistic antimicrobial preparations containing chlorite and hydrogen peroxideFiled 2000·Granted Dec 3, 2002·78 cites·16 claims
- 0393US4997626AMethods to disinfect contact lensesALLERGAN INC·Filed 1990·Granted Mar 5, 1991·71 cites·29 claims
- 0491US10010081B2Synergistic antimicrobial preparations containing chlorite and hydrogen peroxideS K PHARMACEUTICALS INC·Filed 2017·Granted Jul 3, 2018·6 cites·11 claims
- 0589US7544671B2Stabilized hyaluronan preparations and related methodsS K PHARMACEUTICALS INC·Filed 2005·Granted Jun 9, 2009·9 cites·28 claims
- 0689US5866120AMethod for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidaseADVANCED CORNEAL SYSTEMS INC·Filed 1995·Granted Feb 2, 1999·76 cites·9 claims
- 0787US6863886B2Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disordersADVANCED CORNEAL SYSTEMS·Filed 2003·Granted Mar 8, 2005·29 cites·20 claims
- 0886US5626865AEnzyme-orthokeratologyADVANCED CORNEAL SYSTEMS INC·Filed 1992·Granted May 6, 1997·65 cites·46 claims
- 0983US9896480B2Integrin receptor antagonists and their methods of useMACKEL MICHAEL JOHN·Filed 2012·Granted Feb 20, 2018·9 cites·28 claims
- 1082US6939542B2Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vitreous body of the eyeISTA PHARMACEUTICALS INC·Filed 2003·Granted Sep 6, 2005·12 cites·18 claims
- 1182US6551590B2Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vireous body of the eyeISTA PHARMACEUTICALS INC·Filed 1999·Granted Apr 22, 2003·40 cites·17 claims
- 1282US3954965AComposition and method of sterilizing soft contact lenses and method for preventing formation of proteinaceous deposits thereonALLERGAN PHARMA·Filed 1972·Granted May 4, 1976·25 cites·8 claims
- 1381US10590166B2Peptides useable for treating cancerALLEGRO PHARMACEUTICALS LLC·Filed 2018·Granted Mar 17, 2020·3 cites·8 claims
- 1481US6610292B2Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disordersISTA PHARMACEUTICALS INC·Filed 1999·Granted Aug 26, 2003·54 cites·19 claims
- 1580US6737075B2Biochemical methods that eliminate corneal scars, opacification and hazeISTA PHARMACEUTICALS INC·Filed 2001·Granted May 18, 2004·13 cites·15 claims
- 1678US6039943AMethod for accelerating clearance of hemorrhagic blood from the vitreous body with hyaluronidaseADVANCED CORNEAL SYSTEMS·Filed 1998·Granted Mar 21, 2000·33 cites·17 claims
- 1777US5855922AAntiseptic composition and process for prophylaxis and therapeutic treatment of dermal disordersBIO CIDE INTERNATIONAL INC·Filed 1995·Granted Jan 5, 1999·56 cites·8 claims
- 1873US4158700AMethod of producing radioactive technetium-99MKARAGEOZIAN HAMPAR L·Filed 1978·Granted Jun 19, 1979·20 cites·6 claims
- 1972US7141610B2Compositions and methods for the induction of retinal detachmentsISTA PHARMACEUTICALS INC·Filed 2002·Granted Nov 28, 2006·2 cites·10 claims
- 2072US6132735AEnzyme-orthokeratologyISTA PHARMACEUTICAL INC·Filed 1997·Granted Oct 17, 2000·39 cites·5 claims
- 2171US7354416B2Methods and devices for draining fluids and lowering intraocular pressureQUIROZ-MERCADO HUGO·Filed 2004·Granted Apr 8, 2008·70 cites·18 claims
- 2271US2024382557A1Inhibition of tumor necrosis factor, pro-inflammatory cytokines and other inflammatory response mediatorsALLEGRO PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 2370US8288362B2Stabilized glycosaminoglycan preparations and related methodsKARAGEOZIAN HAMPAR·Filed 2007·Granted Oct 16, 2012·1 cites·12 claims
- 2470US2021128604A1Stabilized Glycosaminoglycan Preparations and Related MethodsS K PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2569US5197636AFast activation chlorine dioxide delivery apparatusALLERGAN INC·Filed 1992·Granted Mar 30, 1993·41 cites·30 claims
- 2668US12454549B2Treatments for diseases and disorders that involve oxidative stressJENIUS PHARMA LLC·Filed 2023·Granted Oct 28, 2025·0 cites·5 claims
- 2767US5338480ACompositions and methods to clean contact lensesALLEGAN INC·Filed 1991·Granted Aug 16, 1994·28 cites·25 claims
- 2865US2022313771A1Inhibition of tumor necrosis factor, pro-inflammatory cytokines and other imflammatory response mediatorsALLEGRO PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 2964US9138345B2Optic nerve implantsKARAGEOZIAN HAMPAR L·Filed 2011·Granted Sep 22, 2015·2 cites·12 claims
- 3064US5279673AMethods to disinfect contact lensesALLERGAN INC·Filed 1990·Granted Jan 18, 1994·59 cites·74 claims
- 3164US2020392181A1Peptide compositions and related methodsALLEGRO PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 3264US2020354402A1Peptide compositions and related methodsALLEGRO PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 3363US2006034822A1Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vitreous body of the eyeKARAGEOZIAN HAMPAR L·Filed 2005·Application pending·0 cites
- 3463US2005069531A1Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disordersFiled 2004·Application pending·0 cites
- 3560US2021085749A1Therapeutic and Neuroprotective PeptidesALLEGRO PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 3659US9511088B2Stabalized glycosaminoglycan preparations and related methodsS K PHARMACEUTICALS·Filed 2014·Granted Dec 6, 2016·0 cites·4 claims
- 3759US2019062371A1Peptide compositions and related methodsALLEGRO PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3858US8697671B2Stabilized glycosaminoglycan preparations and related methodsS K PHARMACEUTICALS·Filed 2012·Granted Apr 15, 2014·0 cites·22 claims
- 3957US2018207227A1Therapeutic and Neuroprotective PeptidesALLEGRO PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4056US2017239287A1Stabilized Glycosaminoglycan Preparations and Related MethodsS K PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4155US2025382328A1Treatments for diseases and disorders that involve oxidative stressJENIUS PHARMA LLC·Filed 2025·Application pending·0 cites
- 4254US2015056272A1Synergistic Antimicrobial Preparations Containing Chlorite and Hydrogen PeroxideS K PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4353US2021275624A1Treatments for improving or lessening impairment of mitochondrial functionALLEGRO PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 4452US2022031800A1Peptides for treating non-exudative macular degeneration and other disorders of the eyeALLEGRO PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 4550US2016067084A1Optic Nerve ImplantsS K PHARMACEUTIALS INC·Filed 2015·Application pending·0 cites
- 4649US11673914B2Peptide therapies for reduction of macular thickeningALLEGRO PHARMACEUTICALS LLC·Filed 2020·Granted Jun 13, 2023·0 cites·15 claims
- 4747US2020345805A1Compositions and methods useable for treatment of dry eyeALLEGRO OPHTHALMICS LLC·Filed 2020·Application pending·0 cites
- 4846US5152912AChlorine dioxide precursor containing compositions useful in disinfecting contact lensesALLERGAN INC·Filed 1991·Granted Oct 6, 1992·25 cites·29 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →